You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PSA, Prostate Specific Antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Inflammation, PSA Trial in Albany (Ibuprofen or Naproxen, PSA test)

Recruiting
  • Prostate Cancer
  • +2 more
  • Ibuprofen or Naproxen
  • PSA test
  • Albany, New York
    Albany Medical Center
Nov 29, 2022

Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA

Recruiting
  • Prostatic Neoplasms
  • Radical prostatectomy (RP)
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Jul 14, 2023

PSA, Prostate Cancer Trial in Chicago (Completing surveys)

Active, not recruiting
  • PSA
  • Prostate Cancer
  • Completing surveys
  • Chicago, Illinois
    Mile Square Health Center
Jul 14, 2022

PSA Trial in Chicago (Ibuprofen 400 mg)

Active, not recruiting
  • PSA
  • Ibuprofen 400 mg
  • Chicago, Illinois
    University of Chicago
Aug 21, 2022

Prostate Cancer Trial in Los Angeles (Intervention Session, Printed Material)

Active, not recruiting
  • Prostate Cancer
  • Intervention Session
  • Printed Material
  • Los Angeles, California
    UCLA, Division of Cancer Prevention and Control Research
Jul 1, 2022

Prostate Cancer Trial in Aurora, Fort Collins (Grape Seed Extract)

Recruiting
  • Prostate Cancer
  • Grape Seed Extract
  • Aurora, Colorado
  • +1 more
Aug 22, 2022

Covid19, Prostate Specific Antigen Trial in Ankara (PSA value)

Recruiting
  • Covid19
  • Prostate Specific Antigen
  • PSA value
  • Ankara, Altindag, Turkey
    Omer Gokhan Doluoglu
Aug 15, 2021

Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • Marina Del Rey, California
  • +15 more
Jul 7, 2022

The Effect of IBD Flares on Serum PSA

Recruiting
  • Inflammatory Bowel Diseases
  • Prostate Cancer
  • Blood draw
  • Chicago, Illinois
    Northwestern Medicine
Sep 7, 2021

Stage I Prostate Adenocarcinoma AJCC v7, Stage II Prostate Adenocarcinoma AJCC v7 Trial in United States (Laboratory Biomarker

Active, not recruiting
Has Results
  • Stage I Prostate Adenocarcinoma AJCC v7
  • Stage II Prostate Adenocarcinoma AJCC v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +6 more
Oct 6, 2021

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Prostate Cancer Trial in Zurich ([68Ga]PSMA-11, [18F]PSMA-1007)

Completed
  • Prostate Cancer
  • Zurich, Switzerland
    University Hospital Zurich
Aug 27, 2021

Prostate Cancer Screening, Prostate Cancer Trial in London (Magnetic Resonance Imaging (MRI), Prostate-specific antigen (PSA)

Completed
  • Prostate Cancer Screening
  • Prostate Cancer
  • Magnetic Resonance Imaging (MRI)
  • Prostate-specific antigen (PSA) test
  • London, United Kingdom
    University College London Hospital
Oct 8, 2021

Prostate Adenocarcinoma, PSA Failure, Recurrent Prostate Carcinoma Trial in Palo Alto (Computed Tomography (CT) scan,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Computed Tomography (CT) scan
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jan 6, 2022

Upright MRI for Prostate Cancer Screening

Suspended
  • Prostate Cancer
  • +2 more
  • Upright MRI
  • Standard MRI
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 17, 2021

Prostate Cancer, Elevated Prostate Specific Antigen (PSA) Trial in Brooklyn, New York (serum specimens obtained will be utilized

Active, not recruiting
  • Prostate Cancer
  • Elevated Prostate Specific Antigen (PSA)
  • serum specimens obtained will be utilized for proteomic profiling comprising MALDI-TOF MS, and serum biomarker assays.
  • Brooklyn, New York
  • +2 more
Nov 1, 2022

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

Not yet recruiting
  • Prostate Cancer
  • Darolutamide Oral Tablet [Nubeqa]
  • (no location specified)
Jun 2, 2023

ClarityDX Prostate asReflex Test to Refine Prediction of

Recruiting
  • Prostate Cancer
  • Blood test: ClarityDX Prostate
  • Daytona Beach, Florida
  • +4 more
Jun 16, 2021

dapted Strategy Including Magnetic Resonance Imaging and

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Ankara, Turkey
      Ankara University School of Medicine
    Sep 6, 2023

    Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

    Active, not recruiting
    • Prostate Cancer
    • +5 more
    • 131I-PSMA-1095 Radioligand Therapy (RLT)
    • Montreal, Quebec, Canada
      Stephan Probst
    Oct 24, 2022

    Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

    Recruiting
    • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
    • PSMA radionuclide therapy
    • Dallas, Texas
      Methodist Dallas Medical Center
    Aug 9, 2023

    Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

    Available
    • Castration-Resistant Prostatic Cancer
    • (no location specified)
    Sep 11, 2023

    Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

    Recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • Radionuclide Therapy
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus Medical Center
    Jun 5, 2023

    PET/CT Characterization of Treatment Resistance

    Recruiting
    • Prostate Cancer
    • F-fluorodeoxyglucose positron emission tomography (FDG PET)
    • prostate-specific membrane antigen positron emission tomography (PSMA PET)
    • Madison, Wisconsin
      University of Wisconsin
    Jan 24, 2023